NCT01309698View on ClinicalTrials.gov

Drug Interaction of Vildagliptin (LAF237) With Voglibose in Japanese Patients With Type 2 Diabetes

PHASE4CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

February 28, 2011

Primary Completion Date

April 30, 2011

Conditions
Type 2 Diabetes
Interventions
DRUG

Vildagliptin (LAF237)

DRUG

Voglibose

DRUG

Vildagliptin and Voglibose

Trial Locations (1)

Unknown

Novartis Investigative Site, Tokyo

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY